These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 34014042

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Occludin is a direct target of thyroid transcription factor-1 (TTF-1/NKX2-1).
    Runkle EA, Rice SJ, Qi J, Masser D, Antonetti DA, Winslow MM, Mu D.
    J Biol Chem; 2012 Aug 17; 287(34):28790-801. PubMed ID: 22761434
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Comparative analysis of TTF-1 binding DNA regions in small-cell lung cancer and non-small-cell lung cancer.
    Hokari S, Tamura Y, Kaneda A, Katsura A, Morikawa M, Murai F, Ehata S, Tsutsumi S, Ishikawa Y, Aburatani H, Kikuchi T, Miyazono K, Koinuma D.
    Mol Oncol; 2020 Feb 17; 14(2):277-293. PubMed ID: 31782890
    [Abstract] [Full Text] [Related]

  • 28. An integrative transcriptome analysis reveals a functional role for thyroid transcription factor-1 in small cell lung cancer.
    Horie M, Miyashita N, Mattsson JSM, Mikami Y, Sandelin M, Brunnström H, Micke P, Nagase T, Saito A.
    J Pathol; 2018 Oct 17; 246(2):154-165. PubMed ID: 29876935
    [Abstract] [Full Text] [Related]

  • 29. [Expression and clinical significance of the thyroid transcription factor 1 in Xuanwei lung adenocarcinoma].
    Zu Y, Wang X, Liu X, Chen Y, Li C, Shang X, Xie Y, Zhao H, Wang J.
    Zhongguo Fei Ai Za Zhi; 2013 Mar 17; 16(3):131-7. PubMed ID: 23514941
    [Abstract] [Full Text] [Related]

  • 30. Absence of thyroid transcription factor-1 expression is associated with poor survival in patients with advanced pulmonary adenocarcinoma treated with pemetrexed-based chemotherapy.
    Doherty MK, O'Connor E, Hannon D, O'Reilly A, Yen D, Redmond M, Grogan LM, Hennessy BT, Breathnach OS, Morris PG.
    Ir J Med Sci; 2019 Feb 17; 188(1):69-74. PubMed ID: 29948461
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Thyroid transcription factor-1 level is associated with epidermal growth factor receptor mutation status in patients with advanced lung adenocarcinoma].
    Niu Y, Wang H, Zhang G, Ma J, Wei B, Ma Z.
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Dec 17; 37(12):919-23. PubMed ID: 25609130
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Thyroid transcription factor 1 enhances cellular statin sensitivity via perturbing cholesterol metabolism.
    Lai SC, Phelps CA, Short AM, Dutta SM, Mu D.
    Oncogene; 2018 Jun 17; 37(24):3290-3300. PubMed ID: 29551766
    [Abstract] [Full Text] [Related]

  • 37. MUC5AC enhances tumor heterogeneity in lung adenocarcinoma with mucin production and is associated with poor prognosis.
    Dong Y, Zhou L, Zhao D, Li K, Liu Z, Che N, Liu H.
    Jpn J Clin Oncol; 2020 Jun 10; 50(6):701-711. PubMed ID: 32083303
    [Abstract] [Full Text] [Related]

  • 38. Thyroid transcription factor-1-regulated microRNA-532-5p targets KRAS and MKL2 oncogenes and induces apoptosis in lung adenocarcinoma cells.
    Griesing S, Kajino T, Tai MC, Liu Z, Nakatochi M, Shimada Y, Suzuki M, Takahashi T.
    Cancer Sci; 2017 Jul 10; 108(7):1394-1404. PubMed ID: 28474808
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.